Inactive Instrument

ALZA Corporation Stock

AZA

US0226151084

Biotechnology & Medical Research

End-of-day quote NYSE
-	-

Managers and Directors: ALZA Corporation

Manager	Title	Age	Since
Blake C. Ludwig CEO	Chief Executive Officer	-	-

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	-0.21%	-6.36%	+49.00%	+74.13%	66.34B
LONZA GROUP AG	-0.22%	+6.53%	+11.68%	+90.35%	52.92B
ARGENX SE	+0.82%	+5.41%	+8.05%	+74.45%	54.82B
IQVIA HOLDINGS INC.	+2.71%	+4.96%	+25.76%	+49.70%	44.09B
BEONE MEDICINES AG	+0.88%	+10.34%	+22.84%	+129.86%	43.72B
REVOLUTION MEDICINES, INC.	-0.60%	+1.20%	+266.14%	+967.01%	42.13B
CELLTRION, INC.	+0.10%	+9.96%	+17.15%	+59.33%	33.96B
WUXI BIOLOGICS (CAYMAN) INC.	-1.30%	-3.61%	+37.37%	+7.16%	26.17B
GENMAB A/S	+0.69%	+5.60%	+36.60%	+26.39%	23.37B
Average	+0.28%	+4.78%	+52.73%	+164.26%	43.06B
Weighted average by Cap.	+0.31%	+4.67%	+51.80%	+168.27%

See all sector performances

Provides drug delivery solutions with an array of technology platforms, including oral, transdermal, implantable and liposomal technologies. The Company partners with pharmaceutical and biotechnology companies to develop and manufacture pharmaceutical products that enhance healthcare for patients worldwide.

Employees

Sector

Biotechnology & Medical Research

More about the company